. . . . . "2021-12-16T19:34:14.353772"^^ . "S&T TWOC project version 2" . "2"^^ . "with lenalidomide and dexamethasone alone ( Rd )" . "4"^^ . "compared" . "[221]" . "lenalidomide and dexamethasone ( DRd ) significantly prolonged progression-free survival in transplant-ineligible patients with newly diagnosed multiple myeloma" . "102"^^ . "6bnj8pcp" . "PURPOSE The MAIA trial found that addition of daratumumab to lenalidomide and dexamethasone (DRd) significantly prolonged progression-free survival in transplant-ineligible patients with newly diagnosed multiple myeloma, compared with lenalidomide and dexamethasone alone (Rd)." . "6bnj8pcp-TRIPLE-ABSTRACT-5" . "lenalidomide" . "ineligible" . . "RSA" . "MIGfMA0GCSqGSIb3DQEBAQUAA4GNADCBiQKBgQCSLeezU8JYlBsrgXOGXX4fxOq4oydsMzMK1CN0Rez2OEd2IYk18R4DetcZXwGhN3Pil7qcgNkiGvTirJXIo8zHl7jVehs19EdYtrttCKEaXRzWIr4LuCrfGedkvonEMWqR8e1GdQsLgEEyM50BD6Qw+srQt9ozcqf/9wG2MAMX9QIDAQAB" . "WXGUJrwD+ZMvbxvCrElV5CQbGSP7UdV3vOlYTN4I7t1LrsS8foOC3zstwbwlAmK+OTE2aC3VWWsQYx9VHXaRemzWsToW2lpc4ap6syWu4r/702C0PRvQwsfQE4t5pLXu0Bf53v3ZwOGwO5bHrV/RhM7A+p0tEQLPBanAEBIm2YU=" . . "2021-12-16T19:34:14.353772"^^ . .